221 related articles for article (PubMed ID: 22084433)
41. TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity.
Guerrier T; Youinou P; Pers JO; Jamin C
J Autoimmun; 2012 Sep; 39(3):173-9. PubMed ID: 22695187
[TBL] [Abstract][Full Text] [Related]
42. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation.
Nickerson KM; Christensen SR; Cullen JL; Meng W; Luning Prak ET; Shlomchik MJ
J Immunol; 2013 Feb; 190(4):1447-56. PubMed ID: 23296704
[TBL] [Abstract][Full Text] [Related]
43. Characterization of marginal zone B cell precursors.
Srivastava B; Quinn WJ; Hazard K; Erikson J; Allman D
J Exp Med; 2005 Nov; 202(9):1225-34. PubMed ID: 16260487
[TBL] [Abstract][Full Text] [Related]
44. Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.
Quách TD; Manjarrez-Orduño N; Adlowitz DG; Silver L; Yang H; Wei C; Milner EC; Sanz I
J Immunol; 2011 Apr; 186(8):4640-8. PubMed ID: 21398610
[TBL] [Abstract][Full Text] [Related]
45. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens.
Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ
J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540
[TBL] [Abstract][Full Text] [Related]
46. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors.
Duty JA; Szodoray P; Zheng NY; Koelsch KA; Zhang Q; Swiatkowski M; Mathias M; Garman L; Helms C; Nakken B; Smith K; Farris AD; Wilson PC
J Exp Med; 2009 Jan; 206(1):139-51. PubMed ID: 19103878
[TBL] [Abstract][Full Text] [Related]
47. Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.
Wang JH; Li J; Wu Q; Yang P; Pawar RD; Xie S; Timares L; Raman C; Chaplin DD; Lu L; Mountz JD; Hsu HC
J Immunol; 2010 Jan; 184(1):442-51. PubMed ID: 19949066
[TBL] [Abstract][Full Text] [Related]
48. Tolerant anti-insulin B cells are effective APCs.
Kendall PL; Case JB; Sullivan AM; Holderness JS; Wells KS; Liu E; Thomas JW
J Immunol; 2013 Mar; 190(6):2519-26. PubMed ID: 23396943
[TBL] [Abstract][Full Text] [Related]
49. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.
Zuckerman E; Slobodin G; Kessel A; Sabo E; Yeshurun D; Halas K; Toubi E
Clin Exp Immunol; 2002 May; 128(2):353-8. PubMed ID: 11985527
[TBL] [Abstract][Full Text] [Related]
50. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.
Ni J; Hembrador E; Di Bisceglie AM; Jacobson IM; Talal AH; Butera D; Rice CM; Chambers TJ; Dustin LB
J Immunol; 2003 Mar; 170(6):3429-39. PubMed ID: 12626604
[TBL] [Abstract][Full Text] [Related]
51. Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.
Roughan JE; Reardon KM; Cogburn KE; Quendler H; Pockros PJ; Law M
Clin Vaccine Immunol; 2012 Jul; 19(7):1027-37. PubMed ID: 22623650
[TBL] [Abstract][Full Text] [Related]
52. Marginal zone B cell physiology and disease.
Lopes-Carvalho T; Kearney JF
Curr Dir Autoimmun; 2005; 8():91-123. PubMed ID: 15564718
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis C virus (HCV) infection: serum rheumatoid factor activity and HCV genotype correlate with cryoglobulin clonality.
Antonescu C; Mayerat C; Mantegani A; Frei PC; Spertini F; Tissot JD
Blood; 1998 Nov; 92(9):3486-7. PubMed ID: 9787197
[No Abstract] [Full Text] [Related]
54. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.
Rakhmanov M; Keller B; Gutenberger S; Foerster C; Hoenig M; Driessen G; van der Burg M; van Dongen JJ; Wiech E; Visentini M; Quinti I; Prasse A; Voelxen N; Salzer U; Goldacker S; Fisch P; Eibel H; Schwarz K; Peter HH; Warnatz K
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13451-6. PubMed ID: 19666505
[TBL] [Abstract][Full Text] [Related]
55. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis.
Holz LE; Yoon JC; Raghuraman S; Moir S; Sneller MC; Rehermann B
Hepatology; 2012 Nov; 56(5):1602-10. PubMed ID: 22556016
[TBL] [Abstract][Full Text] [Related]
56. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection.
Curry MP; Golden-Mason L; Nolan N; Parfrey NA; Hegarty JE; O'Farrelly C
J Hepatol; 2000 Jan; 32(1):121-5. PubMed ID: 10673076
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.
Suryani S; Fulcher DA; Santner-Nanan B; Nanan R; Wong M; Shaw PJ; Gibson J; Williams A; Tangye SG
Blood; 2010 Jan; 115(3):519-29. PubMed ID: 19965666
[TBL] [Abstract][Full Text] [Related]
58. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21.
Cariappa A; Tang M; Parng C; Nebelitskiy E; Carroll M; Georgopoulos K; Pillai S
Immunity; 2001 May; 14(5):603-15. PubMed ID: 11371362
[TBL] [Abstract][Full Text] [Related]
59. CD21 and CD62L shedding are both inducible via P2X7Rs.
Sengstake S; Boneberg EM; Illges H
Int Immunol; 2006 Jul; 18(7):1171-8. PubMed ID: 16740600
[TBL] [Abstract][Full Text] [Related]
60. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens.
Zandvoort A; Timens W
Clin Exp Immunol; 2002 Oct; 130(1):4-11. PubMed ID: 12296846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
